Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly.
Looking at options history for Eli Lilly LLY we detected 9 trades.
If we consider the specifics of each trade, it is accurate to state that 55% of the investors opened trades with bullish expectations and 33% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $203,125 and 5, calls, for a total amount of $303,548.
Projected Price Targets
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $600.0 to $890.0 for Eli Lilly over the last 3 months.
Analyzing Volume & Open Interest
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Eli Lilly's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's whale trades within a strike price range from $600.0 to $890.0 in the last 30 days.
Eli Lilly Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | CALL | SWEEP | BULLISH | 03/28/25 | $12.3 | $11.5 | $12.08 | $845.00 | $97.1K | 287 | 107 |
| LLY | PUT | SWEEP | NEUTRAL | 03/28/25 | $10.5 | $9.0 | $9.67 | $840.00 | $96.5K | 467 | 101 |
| LLY | CALL | TRADE | BULLISH | 09/19/25 | $72.2 | $71.1 | $72.2 | $880.00 | $72.2K | 292 | 1 |
| LLY | CALL | TRADE | BEARISH | 03/20/26 | $131.15 | $126.8 | $128.0 | $840.00 | $64.0K | 15 | 5 |
| LLY | PUT | TRADE | BULLISH | 01/16/26 | $90.9 | $86.75 | $86.75 | $840.00 | $43.3K | 643 | 2 |
About Eli Lilly
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
In light of the recent options history for Eli Lilly, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Present Market Standing of Eli Lilly
- Trading volume stands at 186,963, with LLY's price up by 1.03%, positioned at $846.22.
- RSI indicators show the stock to be is currently neutral between overbought and oversold.
- Earnings announcement expected in 38 days.
What The Experts Say On Eli Lilly
1 market experts have recently issued ratings for this stock, with a consensus target price of $1100.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access. * An analyst from Wells Fargo has decided to maintain their Overweight rating on Eli Lilly, which currently sits at a price target of $1100.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Eli Lilly options trades with real-time alerts from Benzinga Pro.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
